Cambridge, MA, United States of America

David Y-w Lee

This inventor holds 3 USPTO granted patents. Top assignee: Natural Pharmacia International, Inc.. Active years: 2010-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David Y-w Lee. Retrieved from https://idiyas.com/inventor/david-y-w-lee

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 13(Granted Patents)


Company Filing History:


Years Active: 2010-2015

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations by David Y-w Lee in Non-Invasive Detection of Tissue Hypoxia

Introduction

David Y-w Lee is an accomplished inventor based in Cambridge, MA (US). He has made significant contributions to the field of medical imaging and treatment through his innovative patents. With a total of 3 patents, his work focuses on the development of compounds that aid in the non-invasive detection of tissue hypoxia.

Latest Patents

One of his latest patents is titled "Weakly basic 2-nitroimidazoles for the non-invasive detection of tissue hypoxia." This invention incorporates weakly basic substituents, such as pyrrolidine, piperidine, piperazine, and azapane moieties in halogenated 2-nitromidazoles. These compounds are designed for the non-invasive detection of cellular hypoxia in both normal and malignant tissues. They can be utilized in positron emission tomography, magnetic resonance spectroscopy, and magnetic resonance imaging.

Another notable patent is "Hypoxia-selective, weakly basic 2-nitroimidazole delivery agents and methods of use thereof." This invention features a class of 2-nitroimidazole compounds that contain a secondary basic nitrogen atom and a linker with therapeutic agents, cytotoxic agents, detectable labels, or chelating groups. Specifically, it provides 2-nitroimidazole compounds containing a cluster of boron atoms for use in boron neutron capture therapy (BNCT). These compounds are aimed at treating hypoxic conditions, including cancer, inflammation, and ischemia, by targeting hypoxic tissue and enhancing overall tissue concentration.

Career Highlights

David Y-w Lee is currently associated with Natural Pharmacia International, Inc., where he continues to innovate in the field of medical research. His work has the potential to significantly impact the diagnosis and treatment of various medical conditions related to tissue hypoxia.

Collaborations

He has collaborated with notable colleagues, including James A Raleigh and Xiao-Shen Ji, to further advance his research and innovations.

Conclusion

David Y-w Lee's contributions to the field of medical imaging and treatment through his innovative patents demonstrate his commitment to improving healthcare solutions. His work in developing non-invasive detection methods for tissue hypoxia is paving the way for advancements in medical diagnostics and therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…